These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19342476)

  • 21. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma.
    Puig N; Pintilie M; Seshadri T; al-Farsi K; Franke N; Keating A; Kuruvilla J; Crump M
    Bone Marrow Transplant; 2011 Oct; 46(10):1339-44. PubMed ID: 21243027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
    Czyz J; Szydlo R; Knopinska-Posluszny W; Hellmann A; Gozdzik J; Hansz J; Smolewski P; Robak T; Osowiecki M; Walewski J; Avigdor A; Nagler A; Zemelka T; Pawlicki M; Sawicki Z; Wojtukiewicz M; Kachel L; Holowiecki J; Charlinski G; Jedrzejczak WW
    Bone Marrow Transplant; 2004 Jun; 33(12):1225-9. PubMed ID: 15094747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fundamental approaches to the treatment of refractory and relapsed Hodgkin lymphoma].
    Filatova LV; Tarasenkova AA; Semiglazova TIu; Gershanovich ML
    Vopr Onkol; 2012; 58(4):443-53. PubMed ID: 23607197
    [No Abstract]   [Full Text] [Related]  

  • 28. Hodgkin's disease and transplantation: a room with a (nontransplanter's) view.
    Marshall NA; DeVita VT
    Semin Oncol; 1999 Feb; 26(1):67-73. PubMed ID: 10073563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital.
    Bacon CL; Daly P; Sheane B; Conneally EC; Browne PV; McCann S; Ni Chongaile M; O'Brian DS; Mc Dermott R; Hollywood D; Wilson L; Vandenberghe E
    Ir Med J; 2009 Jan; 102(1):26-8. PubMed ID: 19284016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
    Bar Ad V; Paltiel O; Glatstein E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy and peripheral hematopoietic stem cell transplantation in relapsed/refractory Hodgkin's lymphoma.
    Kelta M; Zekri J; Abdelghany E; Rehman JU; Khan ZA; Al-Saadi R; Dada R
    Tumori; 2018 Dec; 104(6):471-475. PubMed ID: 28009428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
    Diehl V; Engert A; Re D
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-of-the-art therapeutics: Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.
    Gisselbrecht C
    Br J Haematol; 2008 Dec; 143(5):607-21. PubMed ID: 18950460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line treatment of Hodgkin's lymphoma.
    Klimm B; Engert A; Diehl V
    Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hodgkin's disease--diagnostic basis and therapy in light of randomized clinical trials].
    Jurczak W; Nowak WS; Mensah P; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():90-100. PubMed ID: 10494189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future.
    Isidori A; Piccaluga PP; Loscocco F; Guiducci B; Barulli S; Ricciardi T; Picardi P; Visani G
    Expert Rev Hematol; 2013 Aug; 6(4):451-64. PubMed ID: 23991931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress and controversy in treatment of Hodgkin's disease].
    Robak T
    Acta Haematol Pol; 1995; 26(4):343-52. PubMed ID: 8571735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous and allogeneic stem cell transplantation in follicular lymphoma.
    Van Besien K
    Transfus Apher Sci; 2005 Feb; 32(1):45-53. PubMed ID: 15737873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hodgkin's lymphoma: current treatment strategies and novel approaches.
    Eichenauer DA; Fuchs M; Borchmann P; Engert A;
    Expert Rev Hematol; 2008 Oct; 1(1):63-73. PubMed ID: 21083007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.